Market OverviewFinlify
Price Date: 2026/09/11
ISRG logo

ISRG - Intuitive Surgical Inc

The inventor and dominant provider of robotic-assisted surgery systems, with its da Vinci platform installed in thousands of hospitals globally.

AVOIDWeak Technical SetupCurrent data points to a weaker relative setup or heavier score deductions.
BEATBEAT compares latest EPS results against analyst estimates.

Finlify Score

35.2 / 100

Data Quality

FULL

Penalty

0.0

Sector

Health Care

Close Price

$369.15

+2.41%

52W Range

$328.57 - $603.88

Market Cap

$133.1B

+2.4%

Compared to previous day

2026 Q1 Revenue

$2.8B

-3.3%

Changes from last reporting quarter

2026 Q1 EPS

$2.28

Diluted shares

Analyst Rating

29 Buy10 Hold1 Sell

40 analysts in latest ratings feed

RSI

43.3

40-70 moderate

2Y Range Position

14%

-40.1% from high / +12.4% from low

Beta

1.49

Relative to market benchmark

MACD

-1.06

MACD line -5.43 / signal line -4.37

Fundamental Trend

Growth 38.2
Revenue QoQ-3.3%
Revenue YoY+23.0%
EPS QoQ+3.6%
EPS YoY+18.7%
Gross margin QoQ-0.4%
Operating margin QoQ+0.7%
Net margin QoQ+1.9%

Financial Health

Quality 77.8
Debt / equity-
Debt ratio-
Cash / debt proxy-
Cash / assets+10.0%

Data Quality

FULL
As of date2026-09-11
Latest statement2026-03-31
Penalty0.0
Missing dataNone

Valuation Reference

P/E45.56x
P/B11.26x
P/S12.93x
EV / EBITDA51.14x

Price Chart

Close price, two-year source window

Finlify Score

AVOID

35.2 / 100

Relative Strength7.3 / 100
Accumulation & Volume29.3 / 100
Fundamental Trend38.2 / 100
Financial Quality77.8 / 100
Data Quality FULLNo penalty

Score History

Finlify Score and component trend

Financial Statements

Calendar year view. Figures are estimates only. For official figures, refer to the company website.

2026 Q12025 Q42025 Q32025 Q2
Revenue$2.8B-3.3%$2.9B+14.4%$2.5B+2.7%$2.4B+8.3%
Gross Profit$1.8B-3.9%$1.9B+14.6%$1.7B+2.8%$1.6B+11.0%
Operating Income$855M-1.0%$864M+13.8%$760M+2.2%$743M+28.6%
Net Income$822M+3.4%$795M+12.8%$704M+7.0%$658M-5.7%

Columns use the calendar quarter of each reported period end date. QoQ is shown for adjacent company reporting quarters only.

AI Signal

Generated Aug 1, 2026

The Finlify signal for ISRG is 'AVOID', with a Finlify Score of 46.1/100, which appears to be influenced by weaker fundamental trends and recent price performance despite strong accumulation.

Technical

The asset's Relative Strength score of 5.4/100 suggests significant underperformance compared to the broader market. Recent price action indicates a downward trend, with a -12.3% return over 20 days and a -22.0% return over 60 days, placing it 40.5% below its 52-week high. Despite this, the Accumulation / Volume score of 98.5/100 appears to indicate strong buying interest during this period of decline.

Fundamentals

The Fundamental Trend score of 38.2/100 suggests some weakening in underlying business momentum, although Financial Quality appears robust at 77.8/100. Valuation metrics such as a P/E of 43.6x, P/B of 11.3x, and P/S of 12.4x may indicate a premium valuation for the latest financial period ending 2026-03-31. With a Beta of 1.5, the asset appears to exhibit higher volatility compared to the overall market.

Macro Context

The current macro environment, characterized by an elevated 10Y Treasury Yield of 4.7% and a positive yield spread of 0.5%, may suggest a challenging backdrop for growth-oriented assets like ISRG. Inflation metrics, with CPI YoY at 3.7% and Core PCE YoY at 3.3%, could influence investor sentiment towards future earnings.

Key Risks

  • The asset's Relative Strength of 5.4/100 and significant recent price declines, including a -22.0% return over 60 days, suggest persistent underperformance.
  • A low Fundamental Trend score of 38.2/100, combined with premium valuation multiples such as a P/E of 43.6x, may indicate potential overvaluation relative to its growth prospects.
  • Higher market sensitivity, as indicated by a Beta of 1.5, could expose the asset to increased volatility, particularly in an environment with elevated interest rates.